Inactivation of tumor suppressor genes by promoter methylation is important in the pathogenesis of pancreatic cancer

Cancer Biology and Therapy

Volumn 1, Issue 3, 2002, Pages 297-299

  Fleming, Jason B ^a,b   Minna, John D ^a,b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IGSF4 PROTEIN, HUMAN; IMMUNOGLOBULIN; MEMBRANE PROTEIN; PROTEIN; TUMOR SUPPRESSOR PROTEIN;

CPG ISLAND; DNA METHYLATION; GENE EXPRESSION REGULATION; GENE SILENCING; GENETICS; HETEROZYGOSITY LOSS; HUMAN; NOTE; PANCREAS TUMOR; PATHOLOGY; PROMOTER REGION; TUMOR SUPPRESSOR GENE;

CPG ISLANDS; DNA METHYLATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; GENES, TUMOR SUPPRESSOR; HUMANS; IMMUNOGLOBULINS; LOSS OF HETEROZYGOSITY; MEMBRANE PROTEINS; PANCREATIC NEOPLASMS; PROMOTER REGIONS (GENETICS); PROTEINS; TUMOR SUPPRESSOR PROTEINS;

EID: 1842837162     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.85     Document Type: Note

References (26)

1. Ehrlich M, Gama-Sosa MA, Huang LH, Midgett RM, Kuo KC, McCune RA, et al. Amount and distribution of 5-methylcytosine in human Dna from different types of cells. Nucleic Acids Res 1982; 10:2709-21.
2. Turker MS< Bestor TH. Formation of methylation patterns in the mammalian genome. Mutat Res 1997; 386:119-30. (Pubitemid 27195017)
3. Bird AP. CpG-rich islands and the function of DNA methylation. Nature 1986; 393:209-13. (Pubitemid 16016411)
4. Kafri T, Ariel M, Brandeis M, Shemer R, Urven L, McCarry J, et al. Developmental patterns of gene-specific DNA methylation in the mouse embryo and germ line. Genes Dev 1992; 6:705-14.
5. Falls JG, Pulford DJ, Wylie AA, Jirtle RL. Genomic imprinting: implications for human disease. Am J Path 1999; 154:635-47. (Pubitemid 29122582)
6. Tate PH, Bird AP. Effects of DNA methylation on DNA-binding proteins and gene expression. Curr Opin Genet Dev 1993; 3:226-31. (Pubitemid 23108662)
7. Kass SU, Pruss D, Wolffe AP. How does DNA methylation repress transcription? Trends Genet 1997; 13:444-9.
8. Huang LH, Wang R, Gama-Sosa MA, Shenoy S, Ehrlich M. A protein from human placental nuclei binds preferentially to 5-methylcytosine-rich DNA. Nature 1984; 308:293-295. (Pubitemid 14132039)
9. Knudson AG. Mutation and cancer: statistical study of retinoblastoma. Proc Nat Acad Sci USA 1971; 68:820-3.
10. Jones PA, Laird PW. Cancer epigenetics comes of age. Nat Genetics 1999; 21:163-7. (Pubitemid 29070360)
11. Merlo A, Herman JG, Mao L, Lee DJ, Gabrielson E, Burger PC, et al. 5′CpG Island methylation is associated with transcriptional silencing of the tumor suppressor gene p16/CDKN2/MTS1 in human cancers. Nat Medicine 1995; 1:668-92.
12. Jansen M, Fukushima N, Rosty C, Walter K, Altink R, van Heek T, et al. Aberrent methylation of the 5' CpG island of TSLC1 is common in pancreatic ductal adenocarcinoma and is firs manifest in high-grade PanIN. Cancer Bio Ther 2002; 293-6.
13. Goggins M, Kern S, Offerhaus G, Hruban R. Progress in cancer genetics: lessons from pancreatic cancer. Ann Oncol 1999; 10:4-8.
14. Ueki T, Toyata M, Sohn T, Yeo C, Issa J, Hruban R, et al. Hypermethylation of multiple genes in pancreatic adenocarcinoma. Cancer Res 2000; 60:1835-9. (Pubitemid 30207640)
15. Murakami Y, et al. Localization of tumor suppressor activity important in non small cell lung cancer on chromosome 11q. Proc Nat Acad Sci 1998; 95:8153-8. (Pubitemid 28326082)
16. Wang S, Virmani A, Gazdar A, Minna J, Evans G. Refined mapping of two regions of loss of heterozygosity on chromosome band 11q23 in lung cancer. Genes Chrom Cancer 1999; 25:154-9. (Pubitemid 29226598)
17. Kuramochi M, Fukuhara H, Nobukuni T, Kanbe T, Maruyama T, Ghoch H, et al. TSLC1 is a tumor suppressor gene in human non-small-cell lung cancer. Nat Genetics 2001; 27:427-30. (Pubitemid 32268425)
18. Graff J, Herman J, Lapidus R, Chopra H, Xu R, Jarrard D, et al. E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas. Cancer Res 1995; 55:5195-9.
19. Bachman K, Herman J, Corn P, Merlo A, Costelloa J, Cavenee W, et al. Methylation-associated silencing of the tissue inhibitor of Metalloproteinase-3 gene suggests a suppressor role in kidney, brain and other cancers. Cancer Res 1999; 59:798-802. (Pubitemid 29086729)
20. Li Q, Ahuja N, Burger P, Issa J. Methylation and silencing of thrombospondin-1 promoter in human cancer. Oncogene 1999; 18:3284-9. (Pubitemid 29286973)
21. Hruban R, Adsay V, Albores-Saavedra J, Comptom C, Garrett E, Goodman S, et al. Pancreatic Intraepithelial Neoplasia 2001; 25:579-86.
22. Jutterman R, Li E, Jaenisch R. Toxicity of 5-aza-2′-deoxycytidine to mammalian cells is mediated primarily by covalent trapping of DNA methyltransferase rather than DNA demethylation. Proc Natl Acad Sci USA 1994; 91:11797-801.
23. Ramchandani S, MacLeod AR, Pinard M, von Hofe E, Syzf M. Inhibition of tumorigenesis by cytosine-DNA methyltransferase, antisense oligonucleotide. Proc Natl Acad Sci USA 1997; 94:684-9. (Pubitemid 27053694)
24. Laird PW, Jackson-Grusby L, Fazeli A, Dickinson SL, Jung WE, Li E, et al. Suppression of intestinal neoplasia by DNA hypomethylation. Cell 1995; 81:197-205.
25. Braakhuis B, van Dongen G, Van Walsum M, Leyva A, Snow G. Preclinical antitumor activity of 5-aza-2′-deoxycytidine against human head and neck cancer xenografts. Invest New Drugs 1988; 6:299-304. (Pubitemid 19010328)
26. Momparler R, Samson J, Mamparler L, Rivard G. Cell cycle effects and cellular pharmacology of 5-Aza-2′-deoxycytidine. Cancer Chemother Pharmacol 1984; 13:191-4. (Pubitemid 14048989)